Literature DB >> 27018930

The melting pot of the MHC II peptidome.

Lawrence J Stern1, Laura Santambrogio2.   

Abstract

Recent advances in mass spectrometry technology have facilitated detailed examination of MHC-II immunopeptidomes, for example the repertoires of peptides bound to MHC-II molecules expressed in antigen presenting cells. These studies have deepened our view of MHC-II presentation. Other studies have broadened our view of pathways leading up to peptide loading. Here we review these recent studies in the context of earlier work on conventional and non-conventional MHC-II processing. The message that emerges is that sources of antigen beyond conventional endosomal processing of endocytosed proteins are important for generation of cellular immune responses to pathogens and maintenance of central and peripheral tolerance. The multiplicity of pathways results in a broad MHC II immunopeptidome that conveys the sampled environment to patrolling T cells.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27018930      PMCID: PMC4884503          DOI: 10.1016/j.coi.2016.03.004

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  107 in total

1.  Disruption of multivesicular body vesicles does not affect major histocompatibility complex (MHC) class II-peptide complex formation and antigen presentation by dendritic cells.

Authors:  Berta Bosch; Adam C Berger; Sanjay Khandelwal; Erica L Heipertz; Brian Scharf; Laura Santambrogio; Paul A Roche
Journal:  J Biol Chem       Date:  2013-07-11       Impact factor: 5.157

2.  Mediation by HLA-DM of dissociation of peptides from HLA-DR.

Authors:  V S Sloan; P Cameron; G Porter; M Gammon; M Amaya; E Mellins; D M Zaller
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

Review 3.  Lymph formation, composition and circulation: a proteomics perspective.

Authors:  Kirk C Hansen; Angelo D'Alessandro; Cristina C Clement; Laura Santambrogio
Journal:  Int Immunol       Date:  2015-03-18       Impact factor: 4.823

Review 4.  Autophagy and the immune function in aging.

Authors:  Ana Maria Cuervo; Fernando Macian
Journal:  Curr Opin Immunol       Date:  2014-06-12       Impact factor: 7.486

Review 5.  Chaperone-mediated autophagy: molecular mechanisms and physiological relevance.

Authors:  Samantha J Orenstein; Ana Maria Cuervo
Journal:  Semin Cell Dev Biol       Date:  2010-02-20       Impact factor: 7.727

6.  Protective response to Leishmania major in BALB/c mice requires antigen processing in the absence of DM.

Authors:  Tirumalai Kamala; Navreet K Nanda
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

7.  Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells.

Authors:  Chinnaswamy Jagannath; Devin R Lindsey; Subramanian Dhandayuthapani; Yi Xu; Robert L Hunter; N Tony Eissa
Journal:  Nat Med       Date:  2009-03-01       Impact factor: 53.440

8.  HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide.

Authors:  Anne-Kathrin Anders; Melissa J Call; Monika-Sarah E D Schulze; Kevin D Fowler; David A Schubert; Nilufer P Seth; Eric J Sundberg; Kai W Wucherpfennig
Journal:  Nat Immunol       Date:  2010-12-05       Impact factor: 25.606

9.  Comparison of peptides bound to spleen and thymus class II.

Authors:  P Marrack; L Ignatowicz; J W Kappler; J Boymel; J H Freed
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

10.  HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules.

Authors:  L K Denzin; C Hammond; P Cresswell
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

View more
  17 in total

1.  HLA-DO Modulates the Diversity of the MHC-II Self-peptidome.

Authors:  Padma P Nanaware; Mollie M Jurewicz; John D Leszyk; Scott A Shaffer; Lawrence J Stern
Journal:  Mol Cell Proteomics       Date:  2018-12-20       Impact factor: 5.911

2.  The Human Immunopeptidome Project: A Roadmap to Predict and Treat Immune Diseases.

Authors:  Juan Antonio Vizcaíno; Peter Kubiniok; Kevin A Kovalchik; Qing Ma; Jérôme D Duquette; Ian Mongrain; Eric W Deutsch; Bjoern Peters; Alessandro Sette; Isabelle Sirois; Etienne Caron
Journal:  Mol Cell Proteomics       Date:  2019-11-19       Impact factor: 5.911

Review 3.  Information flow in the spatiotemporal organization of immune responses.

Authors:  Jessica Y Huang; Miranda R Lyons-Cohen; Michael Y Gerner
Journal:  Immunol Rev       Date:  2021-11-29       Impact factor: 12.988

Review 4.  Contribution of the plasma and lymph Degradome and Peptidome to the MHC Ligandome.

Authors:  Laura Santambrogio; Hans-Georg Rammensee
Journal:  Immunogenetics       Date:  2018-10-20       Impact factor: 2.846

Review 5.  Antigen processing and presentation in HIV infection.

Authors:  Julie Boucau; Sylvie Le Gall
Journal:  Mol Immunol       Date:  2018-04-07       Impact factor: 4.407

6.  The MHC Class II Immunopeptidome of Lymph Nodes in Health and in Chemically Induced Colitis.

Authors:  Tim Fugmann; Adriana Sofron; Danilo Ritz; Franziska Bootz; Dario Neri
Journal:  J Immunol       Date:  2016-12-23       Impact factor: 5.422

7.  Creation of an engineered APC system to explore and optimize the presentation of immunodominant peptides of major allergens.

Authors:  Sandra Rosskopf; Sabrina Jutz; Alina Neunkirchner; Martín R Candia; Beatrice Jahn-Schmid; Barbara Bohle; Winfried F Pickl; Peter Steinberger
Journal:  Sci Rep       Date:  2016-08-19       Impact factor: 4.379

8.  Recombinant Lipoprotein Rv1016c Derived from Mycobacterium tuberculosis Is a TLR-2 Ligand that Induces Macrophages Apoptosis and Inhibits MHC II Antigen Processing.

Authors:  Haibo Su; Shenglin Zhu; Lin Zhu; Wei Huang; Honghai Wang; Zhi Zhang; Ying Xu
Journal:  Front Cell Infect Microbiol       Date:  2016-11-18       Impact factor: 5.293

Review 9.  Reciprocal Crosstalk between Dendritic Cells and Natural Killer T Cells: Mechanisms and Therapeutic Potential.

Authors:  Christian W Keller; Stefan Freigang; Jan D Lünemann
Journal:  Front Immunol       Date:  2017-05-24       Impact factor: 7.561

Review 10.  TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential.

Authors:  Mansour Poorebrahim; Niloufar Mohammadkhani; Reza Mahmoudi; Monireh Gholizadeh; Elham Fakhr; Angel Cid-Arregui
Journal:  Cancer Gene Ther       Date:  2021-03-02       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.